AroCell
0,384
SEK
0 %
AROC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 investorer følger denne virksomhed
0%
-5,42%
-26,86%
-4%
-12,13%
-12,73%
-52,17%
-67,93%
-83,88%
AroCell specializes in oncology and bacteriology. The company has a broad product portfolio, and develops, markets and sells blood and urine sample tests that are used by hospitals and clinics. The tests are intended to provide information for the detection of diseases such as urological cancers and typhoid fever. AroCell targets patient groups in different parts of the world. The head office is in Stockholm.
Læs mereMarkedsværdi
88,46 mio. SEK
Aktieomsætning
64,06 t SEK
Omsætning
43,04 mio.
EBIT %
-138,89 %
P/E
-
Udbytteafkast, %
-
Finanskalender
19.2
2025
Årsrapport '24
7.5
2025
Delårsrapport Q1'25
21.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
A new study supports the use of UBC® Rapid in the follow-up of bladder cancer patients
AroCell nomination committee for the AGM 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools